Literature DB >> 13583246

Termination of chlorpromazine with schizophrenic patients.

W W GOOD, M STERLING, W H HOLTZMAN.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; SCHIZOPHRENIA/therapy

Mesh：

Substances：

Year:  1958        PMID： 13583246     DOI： 10.1176/ajp.115.5.443

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

Review 1.  Past and present progress in the pharmacologic treatment of schizophrenia.

Authors:  John M Kane; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

Review 2.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Trial of maintenance therapy in schizophrenia.

Authors:  J P Leff; J K Wing
Journal:  Br Med J       Date:  1971-09-11

4.  Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.

Authors:  Giovanni Ostuzzi; Federico Bertolini; Federico Tedeschi; Giovanni Vita; Paolo Brambilla; Lorenzo Del Fabro; Chiara Gastaldon; Davide Papola; Marianna Purgato; Guido Nosari; Cinzia Del Giovane; Christoph U Correll; Corrado Barbui
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 49.548

5.  Prophylactic effect of neuroleptics in symptom-free schizophrenics.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 6.  Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Authors:  André R Brunoni; Laura Tadini; Felipe Fregni
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.